SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-044747
Filing Date
2024-05-17
Accepted
2024-05-17 16:05:48
Documents
20
Period of Report
2024-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206438-8k_virpax.htm   iXBRL 8-K 45344
2 PLACEMENT AGENCY AGREEMENT, DATED AS OF MAY 14, 2024, BY AND BETWEEN VIRPAX PHAR ea020643801ex1-1_virpax.htm EX-1.1 48742
3 FORM OF SERIES A-1 COMMON WARRANT ea020643801ex4-1_virpax.htm EX-4.1 92305
4 FORM OF SERIES A-2 COMMON WARRANT ea020643801ex4-2_virpax.htm EX-4.2 95448
5 FORM OF PRE-FUNDED WARRANT ea020643801ex4-3_virpax.htm EX-4.3 95965
6 FORM OF SECURITIES PURCHASE AGREEMENT ea020643801ex10-1_virpax.htm EX-10.1 245358
7 PRESS RELEASE DATED MAY 15, 2024 ea020643801ex99-1_virpax.htm EX-99.1 10015
8 GRAPHIC ex99-1_001.jpg GRAPHIC 7797
  Complete submission text file 0001213900-24-044747.txt   975152

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE vrpx-20240514.xsd EX-101.SCH 3027
10 XBRL LABEL FILE vrpx-20240514_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE vrpx-20240514_pre.xml EX-101.PRE 22367
23 EXTRACTED XBRL INSTANCE DOCUMENT ea0206438-8k_virpax_htm.xml XML 3804
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 24959582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)